Latest News and Events in ASI
News:
Applied Spectral Imaging Announces the Launch of the GenASIs Automated Imaging Platforms for
Upcoming Events:
Jan 23-26, 2012
Arab Health 2012, Dubai
Visit ASI at Gulf Scientific Corporation Stand RA20
More Information
More Information
| Diagnosis Made Simple |
|
Applied Spectral Imaging (ASI) makes patient care better through advanced biomedical imaging.
The GenASIs Automated Imaging Platforms for Genetic and Pathological Analysis are the foundation of ASI’s offering. With superior imaging and analysis capabilities, ASI provides state of the art diagnostic aids, offering cytogeneticists and pathologists accurate analysis. GenASIs enables automated tissue analysis for primary diagnostics, with reproducible and reliable results. GenASIs Spectral with HiSKY® adds a new dimension to biomedical image analysis. GenASIs is FDA cleared for clinical applications such as UroVysion, HER2/neu FISH, CEP XY, Karyotyping and FISH. ASI complies with international quality standards including ISO, CE, CMDCAS and 21CFR part 820. ASI is the industry's leading microscopy imaging solution provider since 1993, with over 30 registered patents in the US, Europe, Japan and the rest of the world. With worldwide offices in the US, Europe and Asia, ASI has built a global network of over 50 distributors.
|
